Abbott Laboratories (BVMF:ABTT34)

Abbott Laboratories Statistics

Total Valuation

BVMF:ABTT34 has a market cap or net worth of BRL 1.19 trillion. The enterprise value is 1.22 trillion.

Market Cap	1.19T
Enterprise Value	1.22T

Important Dates

The next estimated earnings date is Thursday, January 22, 2026.

Earnings Date	Jan 22, 2026
Ex-Dividend Date	Oct 14, 2025

Share Statistics

Current Share Class	n/a
Shares Outstanding	n/a
Shares Change (YoY)	-0.04%
Shares Change (QoQ)	-0.08%
Owned by Insiders (%)	0.47%
Owned by Institutions (%)	79.58%
Float	1.73B

Valuation Ratios

The trailing PE ratio is 15.98 and the forward PE ratio is 23.07.

PE Ratio	15.98
Forward PE	23.07
PS Ratio	5.08
PB Ratio	4.34
P/TBV Ratio	10.41
P/FCF Ratio	32.18
P/OCF Ratio	24.41
PEG Ratio	n/a

Enterprise Valuation

The stock's EV/EBITDA ratio is 18.95, with an EV/FCF ratio of 32.98.

EV / Earnings	16.38
EV / Sales	5.24
EV / EBITDA	18.95
EV / EBIT	26.64
EV / FCF	32.98

Financial Position

The company has a current ratio of 1.70, with a Debt / Equity ratio of 0.25.

Current Ratio	1.70
Quick Ratio	1.09
Debt / Equity	0.25
Debt / EBITDA	1.07
Debt / FCF	1.88
Interest Coverage	16.93

Financial Efficiency

Return on equity (ROE) is 30.62% and return on invested capital (ROIC) is 9.03%.

Return on Equity (ROE)	30.62%
Return on Assets (ROA)	6.79%
Return on Invested Capital (ROIC)	9.03%
Return on Capital Employed (ROCE)	12.38%
Revenue Per Employee	2.05M
Profits Per Employee	651,028
Employee Count	114,000
Asset Turnover	0.55
Inventory Turnover	2.84

Taxes

Income Tax	-31.12B
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -0.85% in the last 52 weeks. The beta is 0.72, so BVMF:ABTT34's price volatility has been lower than the market average.

Beta (5Y)	0.72
52-Week Price Change	-0.85%
50-Day Moving Average	58.44
200-Day Moving Average	60.54
Relative Strength Index (RSI)	40.72
Average Volume (20 Days)	858

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	3.52

Income Statement

In the last 12 months, BVMF:ABTT34 had revenue of BRL 233.66 billion and earned 74.22 billion in profits. Earnings per share was 42.43.

Revenue	233.66B
Gross Profit	131.45B
Operating Income	45.92B
Pretax Income	43.37B
Net Income	74.22B
EBITDA	62.60B
EBIT	45.92B
Earnings Per Share (EPS)	42.43

Balance Sheet

The company has 41.21 billion in cash and 69.15 billion in debt, giving a net cash position of -27.94 billion.

Cash & Cash Equivalents	41.21B
Total Debt	69.15B
Net Cash	-27.94B
Net Cash Per Share	n/a
Equity (Book Value)	273.21B
Book Value Per Share	156.17
Working Capital	54.66B

Cash Flow

In the last 12 months, operating cash flow was 48.60 billion and capital expenditures -11.74 billion, giving a free cash flow of 36.86 billion.

Operating Cash Flow	48.60B
Capital Expenditures	-11.74B
Free Cash Flow	36.86B
FCF Per Share	n/a

Margins

Gross margin is 56.26%, with operating and profit margins of 19.65% and 31.88%.

Gross Margin	56.26%
Operating Margin	19.65%
Pretax Margin	18.56%
Profit Margin	31.88%
EBITDA Margin	26.79%
EBIT Margin	19.65%
FCF Margin	15.78%

Dividends & Yields

This stock pays an annual dividend of 0.74, which amounts to a dividend yield of 1.32%.

Dividend Per Share	0.74
Dividend Yield	1.32%
Dividend Growth (YoY)	11.33%
Years of Dividend Growth	5
Payout Ratio	28.93%
Buyback Yield	0.04%
Shareholder Yield	1.36%
Earnings Yield	6.26%
FCF Yield	3.11%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value
Lynch Upside
Graham Number
Graham Upside

Stock Splits

The last stock split was on November 21, 2022. It was a forward split with a ratio of 3.

Last Split Date	Nov 21, 2022
Split Type	Forward
Split Ratio	3

Scores

BVMF:ABTT34 has an Altman Z-Score of 5.83 and a Piotroski F-Score of 6.

Altman Z-Score	5.83
Piotroski F-Score	6